Cargando…

Editorial: Epigenetics in prostate cancer

Detalles Bibliográficos
Autores principales:	Baniahmad, Aria, Ozen, Mustafa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661226/ https://www.ncbi.nlm.nih.gov/pubmed/38023204 http://dx.doi.org/10.3389/fonc.2023.1268519

Ejemplares similares

The Role and Clinical Potentials of Circular RNAs in Prostate Cancer
por: Taheri, Mohammad, et al.
Publicado: (2021)

Importance of long non-coding RNAs in the pathogenesis, diagnosis, and treatment of prostate cancer
por: Taheri, Mohammad, et al.
Publicado: (2023)

Protein translation controlled by the androgen receptor in prostate cancer: a novel therapeutic option?
por: Mirzakhani, Kimia, et al.
Publicado: (2020)

ING Tumour Suppressors and ING Splice Variants as Coregulators of the Androgen Receptor Signalling in Prostate Cancer
por: Melekhova, Anna, et al.
Publicado: (2021)

Editorial: The Role of Epigenetic Modifications in Cancer Progression
por: Fujimura, Atsushi, et al.
Publicado: (2021)

Androgen Receptor-Dependent Mechanisms Mediating Drug Resistance in Prostate Cancer
por: Ehsani, Marzieh, et al.
Publicado: (2021)

Editorial: Epigenetic Modifications in Mesothelioma
por: Cheng, Yuen Yee, et al.
Publicado: (2021)

Editorial: Epigenetics and cellular plasticity in glioblastoma
por: Lo, Hui-Wen, et al.
Publicado: (2023)

Editorial: Epigenetic and metabolic regulation of primary and metastatic brain cancers
por: Gimple, Ryan C., et al.
Publicado: (2023)

Editorial: Radiomics in prostate cancer imaging
por: Brunese, Luca, et al.
Publicado: (2022)

Editorial: Advances in radiotherapy for prostate cancer
por: Kamran, Sophia C., et al.
Publicado: (2022)

Editorial: Mechanisms of Epigenetics and Genetics in Leukemogenesis
por: Li, Yonghui, et al.
Publicado: (2022)

Editorial: Epigenetic Regulation and Tumor Immunotherapy
por: Sun, Hongyin, et al.
Publicado: (2022)

Mechanisms of Androgen Receptor Agonist- and Antagonist-Mediated Cellular Senescence in Prostate Cancer
por: Kokal, Miriam, et al.
Publicado: (2020)

Androgen receptor agonist and antagonist reduce response of cytokine‐induced killer cells on prostate cancer cells
por: Pungsrinont, Thanakorn, et al.
Publicado: (2023)

Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer
por: Pungsrinont, Thanakorn, et al.
Publicado: (2021)

Editorial: Epigenetic insights into diagnostic and therapeutic applications
por: Fratta, Elisabetta, et al.
Publicado: (2023)

Editorial: Stereotactic body radiotherapy for prostate cancer
por: Kishan, Amar U., et al.
Publicado: (2022)

Editorial: Epigenetics and molecular genetics of rare tumors
por: Tognon, Mauro, et al.
Publicado: (2022)

Interplay Between Non-Coding RNAs and Programmed Cell Death Proteins
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022)

CHD1, a multifaceted epigenetic remodeler in prostate cancer
por: Li, Haoyan, et al.
Publicado: (2023)

Distinct mechanisms mediating therapy-induced cellular senescence in prostate cancer
por: Kallenbach, Julia, et al.
Publicado: (2022)

Editorial: Interplay between epigenetic modifiers and transcription factors in driving cancer progression
por: Yang, Yongyong, et al.
Publicado: (2023)

Editorial: The interconnection between epigenetic modifications and the tumor microenvironment
por: He, Siyuan, et al.
Publicado: (2023)

Editorial: Response and Resistance in Castration-Resistant Prostate Cancer
por: de Leeuw, Renée, et al.
Publicado: (2020)

Editorial: Post Operative Radiation Treatment for Prostate Cancer
por: Latorzeff, I., et al.
Publicado: (2022)

The Interaction Between Non-Coding RNAs and Calcium Binding Proteins
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022)

Editorial: Magnetic resonance imaging applications for the diagnosis of prostate cancer
por: Preisser, Felix, et al.
Publicado: (2023)

Editorial: Genetic/epigenetic mechanisms and related clinical strategy in leukemia
por: Li, Yonghui, et al.
Publicado: (2023)

Editorial: Controversies and Perspectives in the Use of Postoperative Radiotherapy for Prostate Cancer
por: Dal Pra, Alan, et al.
Publicado: (2017)

Editorial: Metastatic Castration Resistant Prostate Cancer: Prognosis and Treatment
por: Muniyan, Sakthivel, et al.
Publicado: (2022)

Editorial: The role of epigenetic modification in radiotherapy and immuno-oncology in cancer: from bench to clinical application
por: Lin, Hon-Yi, et al.
Publicado: (2023)

Editorial: The role of transcription factors, stem cell markers and epigenetics contributing to chemoresistance in brain cancers
por: Castresana, Javier S., et al.
Publicado: (2023)

Editorial: Immunotherapy for Prostate Cancer – turning the immunological desert into an oasis of hope
por: Galustian, Christine, et al.
Publicado: (2022)

LncRNA/miRNA/mRNA Network Introduces Novel Biomarkers in Prostate Cancer
por: Taheri, Mohammad, et al.
Publicado: (2022)

Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer
por: Perner, Sven, et al.
Publicado: (2015)

Interaction between Non-Coding RNAs and Androgen Receptor with an Especial Focus on Prostate Cancer
por: Taheri, Mohammad, et al.
Publicado: (2021)

Editorial: Identification of therapeutic targets and novel biomarkers in prostate cancer volume II
por: Sharad, Shashwat, et al.
Publicado: (2023)

Editorial: Altered epigenetic modification mediated dysregulated transcriptional networks in drug resistance
por: Brunetti, Bryce, et al.
Publicado: (2023)

Editorial: The Evolving Landscape of Stereotactic Body Radiation Therapy for the Management of Prostate Cancer
por: Blacksburg, Seth R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p5kbg8376m804rllqc7vok38om